Ligand Pharmaceuticals LGND Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Ligand Pharmaceuticals’s reported figures.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's enterprise value?
- Ligand Pharmaceuticals (LGND) reported enterprise value of $3.87B in Q1 2026.
- How has Ligand Pharmaceuticals's enterprise value changed year-over-year?
- Ligand Pharmaceuticals's enterprise value increased by 95.4% year-over-year, from $1.98B to $3.87B.
- What is the long-term trend for Ligand Pharmaceuticals's enterprise value?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's enterprise value has grown at a 16.8% compound annual growth rate (CAGR), from $1.63B to $3.55B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.